IL13 and colorectal carcinoma: In conclusion, our data reveal that the aggressive properties of IL-13 in CRC were mediated through STAT6-denpendent pathway, and STAT6 directly binds to the promoter of ZEB1 and transcriptional activates its expression and induces EMT process (Figure 6D).